ibandronat sanoswiss 50 mg tabletti, kalvopäällysteinen
sanoswiss uab sanoswiss uab - happo ibandronicum - tabletti, kalvopäällysteinen - 50 mg - ibandronihappo
ibandronat sanoswiss 150 mg tabletti, kalvopäällysteinen
sanoswiss uab sanoswiss uab - happo ibandronicum - tabletti, kalvopäällysteinen - 150 mg - ibandronihappo
pylclari
curium pet france - piflufolastat (18f) - prostatiset kasvaimet - diagnostiset radiofarmaseuttiset valmisteet - tämä lääkevalmiste on tarkoitettu vain diagnostiseen käyttöön. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
dopmin 40 mg/ml infuusiokonsentraatti, liuosta varten
orion corporation - dopamine hydrochloride - infuusiokonsentraatti, liuosta varten - 40 mg/ml - dopamiini